Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
CONVERIDE 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- IRBESARTAN — 300 mg
- HIDROCLOROTIAZIDA — 25 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- No packs currently marketed
Packs
CONVERIDE 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos (Blister PVC/PVDC-Al)
28 pcs
National code
Not marketed719590Strength of this pack 300 mg
CONVERIDE 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos (Blister PVC/PE/PVDC-Al)
28 pcs
National code
Not marketed719592Strength of this pack 300 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 82555Official data
- Marketing authorisation holder
- MEDOCHEMIE IBERIA S.A.Official data
- Authorised
- Oct 30, 2017Official data
- Authority form code
- 42Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.